DEF: Natural Health Trends Seeks Shareholder Approval for 2026 Equity Plan

Sentiment:

Definitive Proxy Statement


Natural Health Trends Corp. will hold its annual meeting on May 7, 2026, to vote on director elections, a new equity incentive plan, and auditor ratification.

Worse than expectedThe company reported a net loss of $882,000 in 2025, a significant deterioration from net income in previous years.Executive and non-employee director phantom share awards granted in April 2025 resulted in substantial forfeitures because the company failed to meet the required positive operating profit and stock appreciation conditions in any of the three quarters the awards were in effect during 2025.Total Shareholder Return (TSR) has shown a consistent decline from 2023 to 2025, indicating poor stock performance.

Summary

  • The annual meeting of stockholders is scheduled for May 7, 2026, at the company's office in Hong Kong.
  • Stockholders will vote on three key proposals: the election of four directors, the approval of the Natural Health Trends Corp. 2026 Equity Incentive Plan, and the ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2026.
  • The Board of Directors recommends a vote FOR all three proposals.
  • The proposed 2026 Equity Incentive Plan, which replaces the expiring 2016 plan, authorizes the issuance of 1,100,000 shares for awards and is designed to attract and retain key personnel.
  • The company reported a net loss of $882,000 in 2025, a significant decline from net income of $572,000 in 2024 and $568,000 in 2023.
  • Executive and non-employee director phantom share awards granted in April 2025 resulted in substantial forfeitures (46,818 for President Sharng, 15,672 for CFO Davidson) because performance conditions were not met in any of the three quarters the awards were in effect during 2025.
  • Total Shareholder Return (TSR) for an initial $100 investment on December 31, 2022, decreased from $194.17 in 2023 to $151.21 in 2025.
  • Two current directors, Yiu T. Chan and Lucy N. Nduati, are not standing for re-election, and Ellen Sun is nominated as a new independent director.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to the reported net loss, significant forfeitures of performance-based executive compensation, and declining Total Shareholder Return, all indicating operational and financial underperformance in 2025.

Positives

  • The proposed 2026 Equity Incentive Plan has a three-year average burn rate of 0.0028% (2023-2025), which is well below the Institutional Shareholder Services, Inc. (ISS) burn rate cap of 1.57% for the company's industry, suggesting responsible share dilution management.
  • The company maintains a robust corporate governance framework, including an Insider Trading Policy that prohibits hedging transactions by employees and directors.
  • All Section 16(a) filing requirements for officers, directors, and greater than ten percent beneficial owners were satisfied in 2025.
  • The Audit Committee has determined that all its members meet independence criteria and qualify as audit committee financial experts.

Negatives

  • The company reported a net loss of $882,000 in 2025, a significant decline from net income of $572,000 in 2024 and $568,000 in 2023.
  • Executive and non-employee director phantom share awards granted in April 2025 resulted in significant forfeitures (46,818 for President Sharng, 15,672 for CFO Davidson) because performance conditions (positive operating profit and stock appreciation) were not met in any of the three quarters the awards were in effect during 2025.
  • Total Shareholder Return (TSR) for an initial $100 investment on December 31, 2022, declined from $194.17 in 2023 to $179.59 in 2024 and further to $151.21 in 2025, indicating poor stock performance over the period.
  • Compensation Actually Paid (CAP) for the PEO and Non-PEO named executive officer decreased significantly from 2023 to 2025, reflecting the company's declining performance.
  • Two current directors, Yiu T. Chan and Lucy N. Nduati, are not standing for re-election, which could signal a loss of experience or a shift in board composition.

Risks

  • Performance-Based Compensation Risk: The failure to meet performance conditions for executive and director phantom share awards in 2025 indicates challenges in achieving financial targets, which could impact future executive motivation and retention if not addressed.
  • Shareholder Dilution: While the proposed 2026 Equity Incentive Plan's burn rate is low, the authorization of 1,100,000 shares for awards still represents approximately 12.8% dilution as of March 19, 2026, which could impact existing shareholder value.
  • Operational Profitability: The company's inability to achieve positive operating profit targets for phantom share vesting conditions in 2025, coupled with a reported net loss, highlights ongoing operational profitability challenges.
  • Executive Retention: The significant forfeitures of performance-based equity awards for executive officers could potentially affect executive morale and retention, especially given the declining total compensation actually paid.
  • Market Volatility: The stock appreciation condition for phantom share vesting, which was not met in 2025, exposes compensation to market volatility and the company's stock performance.

Future Outlook

The filing primarily focuses on past performance and future governance proposals. It states that the grant of awards under the 2026 Equity Incentive Plan is discretionary, and the number or type of awards to be granted in the future to any particular person or group cannot be determined. The Board believes the Equity Plan will be critical in attracting and motivating valuable people essential to the company's future success.

Management Comments

  • The electronic delivery of our proxy materials will reduce our printing and mailing costs and any environmental impact.
  • The Board of Directors believes that the award of incentive compensation continues to be a factor in attracting, motivating and retaining management and other key personnel and that it aligns their interests with those of the Company's stockholders through equity-based compensation that rewards performance based on annual, long-term, and strategic goals.
  • The Company operates in a competitive market and its success depends in large part on its ability to attract, retain and reward talented and competent employees and other service providers. To be able to do so, the Company must offer competitive compensation.
  • As the Company's President since 2007, and as the Chief Financial Officer prior to that, Mr. Sharng has developed a deep understanding of our business globally. His leadership has been integral to our success.
  • The Board of Directors determined to nominate Ms. Sun for election as a director in light of her extensive background in financial reporting and compliance matters and her knowledge of the Company and its operations.

Industry Context

StockSavvy.ai notes that the emphasis on a new equity incentive plan and the detailed disclosure of executive compensation, including performance-based vesting conditions, aligns with broader industry trends where companies use equity to attract and retain talent and align management incentives with shareholder interests. The low burn rate for the proposed plan (0.0028% vs. ISS cap of 1.57%) suggests a conservative approach to dilution compared to some peers, which could be viewed positively by governance-focused investors. However, the company's net loss and declining TSR in 2025 contrast with a generally robust market environment for many health and wellness companies, indicating specific operational challenges. The auditor change due to acquisition is a common occurrence in the accounting industry.

Comparison to Industry Standards

  • The company's three-year average equity plan burn rate of 0.0028% is significantly lower than the Institutional Shareholder Services, Inc. (ISS) burn rate cap of 1.57% for its industry, indicating a more conservative approach to equity compensation dilution compared to global benchmarks.
  • The structure of performance-based phantom share awards, tied to operating profit and stock appreciation, is a common practice in executive compensation across various industries, aiming to align executive incentives with company performance and shareholder value. However, the consistent failure to meet these targets in 2025 suggests underperformance relative to internal benchmarks set for executive compensation.
  • The company's net loss in 2025, contrasting with net income in prior years, indicates a performance deviation from many established health and wellness companies that have shown consistent profitability or growth in recent periods. For example, larger direct selling health companies like Herbalife Nutrition (HLF) or USANA Health Sciences (USNA) typically aim for consistent profitability, though they also face market-specific challenges.
  • The decline in Total Shareholder Return (TSR) from $194.17 in 2023 to $151.21 in 2025 for a $100 initial investment suggests underperformance compared to broader market indices (e.g., S&P 500) and many industry peers over the same period.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorYiu T. ChanN/AMay 7, 2026Not standing for re-election.
DirectorLucy N. NduatiN/AMay 7, 2026Not standing for re-election.
Director NomineeN/AEllen SunMay 7, 2026 (if elected)Nominated for election due to extensive financial reporting and compliance background.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
New Equity Incentive PlanApproval of the Natural Health Trends Corp. 2026 Equity Incentive Plan, replacing the expiring 2016 plan, to provide equity-based compensation to employees, officers, directors, contractors, consultants, or advisors.May 7, 2026 (upon stockholder approval)Aims to attract, motivate, and retain key personnel by aligning their interests with stockholders through performance-based equity awards, with a conservative burn rate.
Auditor AppointmentRatification of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2026, following Marcum LLP's resignation due to an acquisition by CBIZ.December 31, 2026 (fiscal year-end)Ensures continuity of audit services and maintains compliance with regulatory requirements; no reported disagreements during the transition.
Board Composition ChangeTwo current directors (Yiu T. Chan and Lucy N. Nduati) are not standing for re-election, and one new independent director nominee (Ellen Sun) is proposed, leading to a reduction in board size from five to four members.May 7, 2026 (upon election)Changes the board's composition and potentially its dynamics; Ellen Sun's financial expertise is highlighted as a benefit.

Stakeholder Impact

  • Shareholders: Will vote on key governance matters, including director elections and the equity plan, which directly impacts potential dilution and board oversight. The declining TSR and net loss in 2025 are negative for shareholder value.
  • Employees: Eligible to receive awards under the new 2026 Equity Incentive Plan, which aims to attract, motivate, and retain them through equity-based compensation.
  • Management: Executive compensation is tied to performance, with significant forfeitures in 2025 due to unmet targets, directly impacting their total compensation. The new equity plan offers future incentive opportunities.
  • Directors: Compensation includes cash retainers and performance-based phantom shares, which also saw forfeitures in 2025. Board composition is changing with two directors not seeking re-election and one new nominee.
  • Auditors: CBIZ CPAs P.C. is proposed for ratification as the independent registered public accounting firm, ensuring continued external audit oversight.

Next Steps

  • Stockholders to vote on director elections, 2026 Equity Incentive Plan, and auditor ratification at the annual meeting on May 7, 2026.
  • The 2016 Equity Incentive Plan will expire on April 7, 2026.
  • The 2026 Equity Incentive Plan will become effective upon stockholder approval at the annual meeting.
  • Stockholders wishing to submit proposals for the 2027 annual meeting must do so by November 24, 2026 (for inclusion in proxy statement) or February 6, 2027 (under Bylaws).

Key Dates

DateDescription
March 1989Chris T. Sharng started at Mattel, Inc.
December 1994Timothy S. Davidson started at Arthur Andersen, LLP.
February 2000Timothy S. Davidson was Manager of Financial Reporting for IP Communications, Inc.
October 2000Chris T. Sharng was Senior Vice President and CFO of Ultrak Inc.
March 2001Timothy S. Davidson was Corporate Controller for Celion Networks, Inc.
May 2003Randall A. Mason became a director of the Company.
March 2004Chris T. Sharng was CFO of NorthPole Limited.
August 2004Chris T. Sharng became Executive Vice President and CFO of the Company.
September 2004Timothy S. Davidson became Chief Accounting Officer of the Company.
August 2005Ellen Sun was financial controller of the Company's Taiwan subsidiary.
March 2006Randall A. Mason became Chairman of the Board of Directors.
April 2006Chris T. Sharng performed functions of principal executive officer.
February 2007Chris T. Sharng became President of the Company.
February 2007Timothy S. Davidson became CFO and Senior Vice President of the Company.
March 2012Chris T. Sharng became a director.
January 2014Timothy S. Davidson became Corporate Secretary of the Company.
2016Ching C. Wong served as a consultant to the Company.
June 2018Ellen Sun was financial controller at Starlight Investments Inc.
October 2018Ellen Sun served as a consultant to the Company.
May 2019Ellen Sun served as manager of corporate accounting at CPP Investment Board.
June 2020Ching C. Wong became a director of the Company.
2021Ellen Sun rejoined Marquest as chief financial officer.
December 31, 2022Base date for Total Shareholder Return (TSR) calculation.
February 7, 2023Compensation Committee granted phantom shares to executive officers.
December 31, 2023Fiscal year-end for net income and TSR data.
November 1, 2024CBIZ acquired the attest business of Marcum LLP.
December 31, 2024Fiscal year-end for net income, TSR, and audit fees.
March 13, 2025Marcum LLP resigned as independent auditor; CBIZ CPAs P.C. was engaged.
April 1, 2025Board of Directors approved the grant of phantom shares to executive officers and non-employee directors.
May 6, 2025Previous annual stockholders meeting.
December 31, 2025Fiscal year-end for net income, TSR, audit fees, and outstanding equity awards summary.
March 10, 2026Record date for stockholders entitled to vote at the annual meeting.
March 19, 2026Board of Directors approved the 2026 Equity Incentive Plan.
March 24, 2026Proxy statement first sent or given to stockholders.
April 7, 2026The 2016 Equity Incentive Plan is scheduled to expire.
May 7, 2026Date of the 2026 annual meeting of stockholders.
November 24, 2026Deadline for stockholder proposals for the 2027 annual meeting (for inclusion in proxy statement).
December 31, 2026Fiscal year-end for which CBIZ CPAs P.C. is proposed as independent auditor.
February 6, 2027Deadline for stockholder proposals for the 2027 annual meeting (under Bylaws).
March 8, 2027Deadline for notice of proxy solicitation for director nominees for 2027 annual meeting.

Recommendation

sell

The company reported a net loss of $882,000 in 2025, a significant reversal from prior years' profitability. This, coupled with a consistent decline in Total Shareholder Return (TSR) from $194.17 in 2023 to $151.21 in 2025, indicates severe underperformance. The failure to meet performance conditions for executive and director equity awards further underscores operational challenges. While the proxy statement outlines governance matters, the underlying financial results and stock performance suggest a deteriorating business outlook, warranting a "sell" recommendation for seasoned investors.

Keywords

Natural Health Trends Corp, NHTC, Proxy Statement, DEF 14A, Annual Meeting, Director Election, Equity Incentive Plan, Executive Compensation, Corporate Governance, Auditor Ratification, Net Loss, Shareholder Return, Phantom Shares, Compensation Forfeitures, Board of Directors, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.